,reactionmeddraversionpt,reactionmeddrapt,reactionoutcome,safetyreportid
0,22.0,Renal failure,1,16467676
1,22.0,Vomiting,1,16467676
2,22.0,Diarrhoea,1,16467676
0,22.0,Tumour invasion,6,16467682
1,22.0,Metastases to lymph nodes,6,16467682
2,22.0,Sarcoma uterus,6,16467682
0,22.0,Drug ineffective,5,16467704
1,22.0,Malignant neoplasm progression,5,16467704
2,22.0,Metastases to central nervous system,5,16467704
0,22.0,Oestrogen receptor assay positive,3,16467778
1,22.0,Back pain,3,16467778
2,22.0,Arthralgia,3,16467778
3,22.0,Abdominal lymphadenopathy,3,16467778
4,22.0,Clubbing,3,16467778
5,22.0,Dysuria,3,16467778
6,22.0,Carbohydrate antigen 15-3 increased,3,16467778
7,22.0,Hepatic steatosis,3,16467778
8,22.0,Human epidermal growth factor receptor negative,3,16467778
9,22.0,Ovarian mass,3,16467778
10,22.0,Progesterone receptor assay positive,3,16467778
11,22.0,Frequent bowel movements,3,16467778
12,22.0,Urge incontinence,3,16467778
13,22.0,Uterine leiomyoma,3,16467778
14,22.0,Metastases to liver,3,16467778
15,22.0,Uterine enlargement,3,16467778
16,22.0,Palmar-plantar erythrodysaesthesia syndrome,3,16467778
17,22.0,Vertebral column mass,3,16467778
18,22.0,Breast cancer metastatic,3,16467778
19,22.0,Pelvic mass,3,16467778
0,22.0,General physical health deterioration,6,16467823
1,22.0,Respiratory failure,5,16467823
2,22.0,Prostate cancer,5,16467823
3,22.0,Mobility decreased,3,16467823
4,22.0,Metastases to bone,3,16467823
5,22.0,Haemoglobin decreased,3,16467823
6,22.0,Blood urine present,3,16467823
7,22.0,Metastasis,3,16467823
0,22.0,Breast cancer,6,16467858
0,22.0,Breast cancer metastatic,6,16467880
0,22.0,Disease progression,6,16467882
0,22.0,Blood pressure decreased,1,16467884
1,22.0,Tachycardia,1,16467884
2,22.0,Pyrexia,1,16467884
0,22.0,Diarrhoea,1,16467892
1,22.0,Weight loss poor,1,16467892
0,22.0,Drug interaction,6,16467918
1,22.0,Acute kidney injury,1,16467918
2,22.0,Hyperkalaemia,1,16467918
3,22.0,Metabolic acidosis,1,16467918
4,22.0,Cardio-respiratory arrest,1,16467918
0,22.0,Encephalopathy,5,16467938
1,22.0,Dyskinesia,1,16467938
0,22.1,Rash,6,16467960
1,22.1,Prostatic specific antigen increased,6,16467960
2,22.1,Rash macular,6,16467960
0,22.0,Gastric perforation,5,16467968
1,22.0,Hypertension,3,16467968
2,22.0,Respiratory failure,3,16467968
3,22.0,Acute kidney injury,3,16467968
4,22.0,Sepsis,3,16467968
5,22.0,Pneumonitis,3,16467968
6,22.0,Seizure,3,16467968
7,22.0,Fatigue,3,16467968
8,22.0,Troponin T increased,3,16467968
9,22.0,Hyponatraemia,3,16467968
0,22.0,Breast cancer metastatic,6,16467969
0,22.0,Malignant neoplasm progression,6,16467972
1,22.0,Metastases to liver,6,16467972
0,22.0,Myelitis transverse,3,16467973
0,22.0,Influenza,6,16468081
1,22.0,Intra-abdominal haemorrhage,6,16468081
0,22.0,Drug ineffective,6,16468091
1,22.0,Breast cancer,6,16468091
2,22.0,Malignant neoplasm progression,6,16468091
0,22.0,Nausea,1,16468097
1,22.0,Reflux gastritis,1,16468097
2,22.0,Constipation,1,16468097
0,22.1,Neutropenia,1,16468106
1,22.1,Nasopharyngitis,1,16468106
2,22.1,Pain,3,16468106
3,22.1,Ill-defined disorder,1,16468106
4,22.1,Weight decreased,3,16468106
0,22.0,Malaise,3,16468129
0,22.0,Deep vein thrombosis,1,16468209
0,22.0,Alanine aminotransferase abnormal,6,16468217
1,22.0,Alopecia,6,16468217
2,22.0,Aspartate aminotransferase abnormal,6,16468217
3,22.0,Neurotoxicity,6,16468217
4,22.0,Oral disorder,6,16468217
5,22.0,Granulocytopenia,6,16468217
6,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16468217
7,22.0,Diarrhoea,6,16468217
8,22.0,Gastrointestinal disorder,6,16468217
9,22.0,Thrombocytopenia,6,16468217
10,22.0,Haemoglobin decreased,6,16468217
0,22.1,Glossodynia,6,16468233
1,22.1,Lip pain,6,16468233
2,22.1,Abdominal pain upper,6,16468233
3,22.1,Musculoskeletal chest pain,1,16468233
4,22.1,Pain,6,16468233
5,22.1,Constipation,6,16468233
6,22.1,Abdominal discomfort,6,16468233
0,22.0,Loss of consciousness,5,16468242
1,22.0,Intestinal ischaemia,5,16468242
2,22.0,Disseminated intravascular coagulation,5,16468242
3,22.0,Gas gangrene,5,16468242
4,22.0,Bone marrow failure,6,16468242
5,22.0,Gastroenteritis,5,16468242
6,22.0,Abdominal pain,5,16468242
7,22.0,Necrotising colitis,5,16468242
8,22.0,Respiratory arrest,5,16468242
9,22.0,Multiple organ dysfunction syndrome,5,16468242
10,22.0,Septic shock,5,16468242
11,22.0,Clostridial infection,5,16468242
12,22.0,Dehydration,5,16468242
13,22.0,Diarrhoea,5,16468242
14,22.0,Neutrophil count decreased,6,16468242
15,22.0,Leukopenia,6,16468242
16,22.0,Vomiting,5,16468242
0,22.0,Malignant neoplasm progression,6,16468252
1,22.0,Metastases to bone,6,16468252
2,22.0,Drug intolerance,6,16468252
3,22.0,Breast cancer metastatic,6,16468252
4,22.0,Skin mass,6,16468252
0,22.0,Tuberculosis,6,16468253
0,22.0,Malignant neoplasm progression,6,16468304
0,22.0,Synovial cyst,6,16468331
1,22.0,Disease recurrence,6,16468331
2,22.0,Malignant neoplasm progression,6,16468331
3,22.0,Breast cancer,6,16468331
4,22.0,Drug ineffective,6,16468331
0,22.0,Papilloedema,6,16468333
1,22.0,Skin reaction,6,16468333
2,22.0,Malignant neoplasm progression,6,16468333
3,22.0,Weight increased,6,16468333
4,22.0,Jugular vein thrombosis,6,16468333
5,22.0,Subclavian vein thrombosis,6,16468333
0,22.0,Cardio-respiratory arrest,1,16468347
1,22.0,Acute kidney injury,1,16468347
2,22.0,Hyperkalaemia,1,16468347
3,22.0,Metabolic acidosis,1,16468347
0,22.0,Lung disorder,6,16468386
0,22.0,Internal haemorrhage,6,16468422
0,22.1,Thrombosis,6,16468451
1,22.1,Alopecia,3,16468451
0,22.0,Immune system disorder,3,16468457
1,22.0,Pyrexia,3,16468457
0,22.0,Neoplasm progression,6,16468462
1,22.0,Bone marrow failure,6,16468462
2,22.0,Neutropenia,6,16468462
3,22.0,Anaemia,6,16468462
4,22.0,Muscle spasms,6,16468462
0,22.1,Musculoskeletal disorder,6,16468465
1,22.1,Wrong strength,6,16468465
2,22.1,Blindness unilateral,6,16468465
0,22.0,Depressed level of consciousness,6,16468471
0,22.0,Headache,3,16468495
1,22.0,Contusion,3,16468495
2,22.0,Epilepsy,1,16468495
0,22.1,Face oedema,6,16468506
1,22.1,Nausea,6,16468506
2,22.1,Disseminated intravascular coagulation,5,16468506
3,22.1,Catheter site haemorrhage,6,16468506
4,22.1,Interstitial lung disease,5,16468506
5,22.1,Decreased appetite,3,16468506
0,22.0,Neoplasm progression,1,16468522
1,22.0,Dyspnoea,3,16468522
2,22.0,Weight fluctuation,3,16468522
3,22.0,White blood cell count decreased,3,16468522
4,22.0,Chest pain,3,16468522
0,22.0,Palpitations,1,16468545
1,22.0,Hypotension,1,16468545
2,22.0,Urticaria,1,16468545
0,22.0,Carotid artery dissection,2,16468548
1,22.0,Type I hypersensitivity,1,16468548
2,22.0,Abdominal pain upper,1,16468548
3,22.0,Erythema,1,16468548
4,22.0,Paraesthesia,1,16468548
5,22.0,Hypertension,1,16468548
0,22.0,Respiratory tract infection,1,16468549
0,22.0,Anxiety,6,16468556
0,22.0,Malaise,2,16468563
1,22.0,Constipation,6,16468563
2,22.0,Vomiting,6,16468563
3,22.0,Pain,2,16468563
0,22.0,Acute myocardial infarction,5,16468566
0,22.0,Death,5,16468594
1,22.0,Nausea,6,16468594
2,22.0,Vomiting,6,16468594
3,22.0,Seizure,6,16468594
4,22.0,Abdominal pain upper,6,16468594
0,22.0,Angiopathy,6,16468631
0,22.0,Injury,6,16468632
1,22.0,Road traffic accident,6,16468632
0,22.0,Lung infection,6,16468641
0,22.0,Death,5,16468674
0,22.0,Death,5,16468677
0,22.0,Death,5,16468678
0,22.1,Decreased appetite,3,16468690
1,22.1,Oropharyngeal discomfort,1,16468690
2,22.1,Hepatic enzyme increased,6,16468690
3,22.1,Anaemia,6,16468690
4,22.1,Lung neoplasm malignant,1,16468690
5,22.1,Nausea,3,16468690
6,22.1,Stress,3,16468690
7,22.1,Product dose omission,3,16468690
8,22.1,Thrombosis,3,16468690
9,22.1,Rhinorrhoea,1,16468690
10,22.1,Skin exfoliation,1,16468690
11,22.1,Fatigue,3,16468690
12,22.1,Sleep disorder,1,16468690
13,22.1,Dizziness,6,16468690
14,22.1,Product use in unapproved indication,6,16468690
0,22.0,Hepatotoxicity,1,16468717
1,22.0,Vomiting,6,16468717
2,22.0,Off label use,6,16468717
3,22.0,White blood cell count decreased,6,16468717
4,22.0,Nausea,6,16468717
5,22.0,Anaemia,6,16468717
6,22.0,Oral disorder,2,16468717
7,22.0,Intentional product use issue,6,16468717
8,22.0,Diarrhoea,2,16468717
9,22.0,Platelet count decreased,6,16468717
10,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16468717
11,22.0,Alopecia,6,16468717
12,22.0,Constipation,2,16468717
0,22.0,Palpitations,6,16468731
1,22.0,Off label use,6,16468731
0,22.0,Intestinal obstruction,3,16468742
1,22.0,Constipation,3,16468742
0,22.1,Anal pruritus,1,16468756
1,22.1,Nausea,3,16468756
2,22.1,Polyneuropathy,3,16468756
3,22.1,Muscular weakness,3,16468756
4,22.1,Decreased appetite,3,16468756
5,22.1,Haematochezia,1,16468756
6,22.1,Dyspnoea,3,16468756
7,22.1,Epistaxis,1,16468756
8,22.1,Ear infection,3,16468756
9,22.1,Dry skin,1,16468756
10,22.1,Constipation,1,16468756
11,22.1,Headache,3,16468756
12,22.1,Anal pruritus,1,16468756
13,22.1,Vomiting,1,16468756
14,22.1,Erythema of eyelid,1,16468756
15,22.1,Neutropenia,1,16468756
16,22.1,Pruritus genital,1,16468756
17,22.1,Abdominal discomfort,1,16468756
18,22.1,Alopecia,1,16468756
19,22.1,Paraesthesia,1,16468756
20,22.1,Nausea,1,16468756
21,22.1,Diarrhoea,1,16468756
22,22.1,Erythema,1,16468756
23,22.1,Eye pain,1,16468756
24,22.1,Decreased appetite,1,16468756
25,22.1,Haemoptysis,1,16468756
26,22.1,Dysphagia,3,16468756
27,22.1,Abdominal pain,1,16468756
28,22.1,Abdominal pain,3,16468756
29,22.1,Fatigue,1,16468756
30,22.1,Dyspepsia,1,16468756
31,22.1,Mucosal inflammation,1,16468756
32,22.1,Rhinorrhoea,3,16468756
33,22.1,Abdominal distension,1,16468756
0,22.0,Asthenia,,16468791
1,22.0,Syncope,,16468791
2,22.0,Diarrhoea,,16468791
3,22.0,Therapy cessation,,16468791
0,22.0,Cardiomyopathy,3,16468810
0,22.0,Metastases to central nervous system,5,16468816
1,22.0,Muscular weakness,6,16468816
2,22.0,Pneumonia aspiration,5,16468816
3,22.0,Urinary retention,6,16468816
0,22.0,Dyspnoea,5,16468836
1,22.0,Pericarditis,5,16468836
2,22.0,Tachycardia,5,16468836
0,22.1,Pain,6,16468856
1,22.1,Vomiting,6,16468856
2,22.1,Nausea,6,16468856
3,22.1,Stomatitis,6,16468856
4,22.1,Abdominal pain upper,6,16468856
5,22.1,Abdominal discomfort,6,16468856
6,22.1,Headache,6,16468856
0,22.0,Neoplasm progression,6,16468861
0,22.0,Diarrhoea,6,16468864
1,22.0,Fatigue,6,16468864
0,22.1,Muscle injury,1,16468871
0,22.1,Blood count abnormal,6,16468875
1,22.1,Alopecia,3,16468875
2,22.1,Emotional disorder,1,16468875
3,22.1,Fatigue,3,16468875
4,22.1,Headache,6,16468875
5,22.1,Crying,1,16468875
6,22.1,Laboratory test abnormal,6,16468875
7,22.1,White blood cell count decreased,6,16468875
0,22.1,Laboratory test abnormal,6,16468883
1,22.1,Infection,6,16468883
2,22.1,Blood count abnormal,6,16468883
3,22.1,Urinary tract infection,6,16468883
0,22.0,Neoplasm progression,6,16468886
0,22.0,Neoplasm progression,6,16468893
0,22.0,Pain,6,16468901
1,22.0,Neoplasm progression,6,16468901
0,22.1,Decreased appetite,1,16468968
1,22.1,White blood cell count decreased,1,16468968
2,22.1,Anaemia,1,16468968
3,22.1,Fall,1,16468968
4,22.1,Product dose omission,6,16468968
5,22.1,Colitis,6,16468968
6,22.1,Pancytopenia,6,16468968
7,22.1,Dental care,1,16468968
8,22.1,Urinary tract infection,3,16468968
9,22.1,Limb discomfort,6,16468968
10,22.1,Constipation,6,16468968
11,22.1,Malaise,6,16468968
12,22.1,Dysgeusia,6,16468968
13,22.1,Balance disorder,1,16468968
14,22.1,Hypertension,1,16468968
15,22.1,Nausea,1,16468968
16,22.1,Inappropriate schedule of product administration,6,16468968
0,22.0,Abdominal pain,1,16468973
1,22.0,Constipation,3,16468973
2,22.0,Vomiting,1,16468973
3,22.0,Product use complaint,3,16468973
4,22.0,Product size issue,3,16468973
0,22.1,Product dispensing error,6,16468998
1,22.1,Neoplasm progression,6,16468998
0,22.0,Platelet count abnormal,2,16469006
1,22.0,Lymphoedema,3,16469006
2,22.0,Gastrointestinal disorder,3,16469006
3,22.0,White blood cell count abnormal,2,16469006
0,22.0,Drug hypersensitivity,6,16469010
0,22.0,Nasopharyngitis,6,16469028
1,22.0,Malaise,6,16469028
2,22.0,Fatigue,6,16469028
3,22.0,White blood cell count decreased,6,16469028
0,22.0,Hypersensitivity,6,16469043
1,22.0,Mouth ulceration,6,16469043
2,22.0,Cough,6,16469043
3,22.0,Pain,6,16469043
4,22.0,Fatigue,6,16469043
5,22.0,Somnolence,6,16469043
0,22.0,Full blood count decreased,2,16469047
0,22.0,Hypotension,5,16469077
1,22.0,Superior vena cava syndrome,3,16469077
0,22.0,Psychological trauma,6,16469108
1,22.0,Alopecia,3,16469108
0,22.0,Psychological trauma,6,16469110
1,22.0,Pain,6,16469110
2,22.0,Alopecia,3,16469110
3,22.0,Emotional distress,6,16469110
4,22.0,Anxiety,6,16469110
5,22.0,Impaired quality of life,6,16469110
0,22.0,Psychological trauma,6,16469112
1,22.0,Alopecia,3,16469112
0,22.0,Alopecia,2,16469115
1,22.0,Psychological trauma,6,16469115
0,22.0,Psychological trauma,6,16469116
1,22.0,Alopecia,2,16469116
0,22.0,Cerebrovascular accident,,16469119
0,22.0,Alopecia,3,16469121
0,22.0,Alopecia,3,16469122
1,22.0,Psychological trauma,6,16469122
0,22.0,Alopecia,3,16469131
1,22.0,Psychological trauma,6,16469131
0,22.0,Disease progression,,16469157
0,22.0,Anaemia,6,16469163
1,22.0,Sepsis,1,16469163
2,22.0,Tachycardia,6,16469163
3,22.0,Pneumonia,1,16469163
4,22.0,Leukocytosis,6,16469163
5,22.0,Hypokalaemia,6,16469163
6,22.0,Breath sounds abnormal,6,16469163
7,22.0,Hyponatraemia,6,16469163
8,22.0,Pyrexia,1,16469163
9,22.0,Pulmonary embolism,6,16469163
10,22.0,Thrombocytopenia,1,16469163
11,22.0,Hepatic cancer metastatic,6,16469163
12,22.0,Rales,6,16469163
13,22.0,Asthenia,1,16469163
14,22.0,Thrombosis,6,16469163
0,22.0,Metastases to liver,6,16469176
1,22.0,Malignant neoplasm progression,6,16469176
2,22.0,Gastric disorder,6,16469176
3,22.0,Arthralgia,6,16469176
4,22.0,Insomnia,6,16469176
0,22.0,Renal injury,6,16469178
1,22.0,Chronic kidney disease,3,16469178
2,22.0,Rebound acid hypersecretion,6,16469178
3,22.0,Renal failure,6,16469178
0,22.0,Labile hypertension,3,16469196
1,22.0,Head discomfort,3,16469196
2,22.0,Blood pressure systolic increased,3,16469196
0,22.0,Disease progression,3,16469198
0,22.0,Alopecia,3,16469222
0,22.0,Pancytopenia,6,16469239
1,22.0,Gastrointestinal haemorrhage,6,16469239
0,22.0,Psychological trauma,6,16469253
1,22.0,Pain,6,16469253
2,22.0,Alopecia,2,16469253
3,22.0,Anxiety,6,16469253
4,22.0,Emotional distress,6,16469253
5,22.0,Impaired quality of life,6,16469253
0,22.0,Malignant neoplasm progression,6,16469271
0,22.0,Thrombocytopenia,,16469276
1,22.0,Gastrointestinal haemorrhage,,16469276
2,22.0,Blood loss anaemia,,16469276
0,22.1,Pain,6,16469281
1,22.1,Emotional distress,6,16469281
2,22.1,Alopecia,2,16469281
3,22.1,Anxiety,6,16469281
4,22.1,Impaired quality of life,6,16469281
5,22.1,Psychological trauma,6,16469281
0,22.0,Diarrhoea,,16469293
1,22.0,Therapy cessation,,16469293
2,22.0,Nausea,,16469293
3,22.0,Herpes zoster,,16469293
0,22.0,Nausea,5,16469314
1,22.0,Weight increased,6,16469314
2,22.0,Acute myocardial infarction,5,16469314
3,22.0,Chest pain,5,16469314
4,22.0,Lung infiltration,5,16469314
5,22.0,Cardiogenic shock,5,16469314
6,22.0,Bundle branch block left,5,16469314
7,22.0,Ventricular hypokinesia,5,16469314
8,22.0,Fatigue,5,16469314
9,22.0,Dyspnoea,5,16469314
10,22.0,Tachycardia,5,16469314
11,22.0,General physical health deterioration,5,16469314
12,22.0,Vomiting,5,16469314
13,22.0,Hypotension,5,16469314
0,22.0,Rectal haemorrhage,,16469315
1,22.0,Subarachnoid haemorrhage,,16469315
2,22.0,Subdural haemorrhage,,16469315
0,22.0,Depression,6,16469316
0,22.0,Pulmonary embolism,6,16469329
0,22.0,Myocardial infarction,5,16469334
0,22.0,Hepatic encephalopathy,,16469347
1,22.0,Hepatic encephalopathy,,16469347
0,22.0,Hormone-refractory prostate cancer,,16469348
1,22.0,Metastases to bone,,16469348
2,22.0,Urinary bladder haemorrhage,,16469348
0,22.0,No adverse event,6,16469361
1,22.0,Product availability issue,6,16469361
2,22.0,Product dose omission,6,16469361
0,22.0,Palpitations,,16469397
1,22.0,Infusion related reaction,,16469397
2,22.0,Chest discomfort,,16469397
0,22.1,Alopecia,2,16469470
1,22.1,Psychological trauma,6,16469470
0,22.1,Hypertension,6,16469480
1,22.1,Cough,3,16469480
2,22.1,Fatigue,3,16469480
0,22.0,Back pain,6,16469481
1,22.0,Chest pain,6,16469481
0,22.0,Pneumonia,6,16469568
1,22.0,Cardiac failure,6,16469568
2,22.0,Anxiety,6,16469568
3,22.0,Dyspnoea,6,16469568
0,22.0,Drug resistance,5,16469572
1,22.0,Treatment failure,5,16469572
0,22.1,Ovarian cancer recurrent,6,16469621
1,22.1,Product use in unapproved indication,6,16469621
2,22.1,Neurotoxicity,2,16469621
3,22.1,Off label use,6,16469621
0,22.0,Renal failure,5,16469639
1,22.0,Febrile neutropenia,3,16469639
2,22.0,Bone marrow failure,6,16469639
0,22.1,Alopecia,3,16469688
1,22.1,Psychological trauma,6,16469688
0,22.0,Alopecia,3,16469701
1,22.0,Psychological trauma,6,16469701
0,22.1,Alopecia,2,16469715
1,22.1,Emotional distress,6,16469715
0,22.0,Treatment failure,5,16469737
1,22.0,Drug resistance,5,16469737
0,22.1,Alopecia,2,16469854
1,22.1,Psychological trauma,6,16469854
0,22.0,Alopecia,2,16469857
1,22.0,Emotional distress,6,16469857
2,22.0,Psychological trauma,6,16469857
0,22.0,Psychological trauma,6,16469870
1,22.0,Alopecia,2,16469870
0,22.0,Perirectal abscess,6,16469929
1,22.0,Febrile neutropenia,6,16469929
2,22.0,White blood cell count decreased,6,16469929
3,22.0,Neutropenia,6,16469929
4,22.0,Suture rupture,6,16469929
5,22.0,Neutrophil count decreased,6,16469929
6,22.0,Anaemia,6,16469929
7,22.0,Leukopenia,6,16469929
8,22.0,Female genital tract fistula,6,16469929
0,22.0,Dyspnoea,2,16469979
1,22.0,Perineal pain,2,16469979
2,22.0,Oxygen saturation decreased,2,16469979
3,22.0,Erythema,1,16469979
4,22.0,Irritability,1,16469979
5,22.0,Oral discomfort,2,16469979
6,22.0,Hyperhidrosis,2,16469979
7,22.0,Palpitations,2,16469979
8,22.0,Hypersensitivity,1,16469979
0,22.0,Toxicity to various agents,1,16470062
0,22.0,Dysuria,3,16470066
1,22.0,Nausea,6,16470066
2,22.0,Rash,6,16470066
3,22.0,Dyspepsia,6,16470066
4,22.0,Vomiting,6,16470066
5,22.0,Back pain,3,16470066
6,22.0,Fluid retention,6,16470066
7,22.0,Insomnia,3,16470066
8,22.0,Fatigue,6,16470066
9,22.0,Neuropathy peripheral,6,16470066
10,22.0,Constipation,6,16470066
11,22.0,Dehydration,6,16470066
12,22.0,Adverse drug reaction,6,16470066
0,22.0,Fulminant type 1 diabetes mellitus,6,16470068
0,22.1,Hypersomnia,3,16470073
1,22.1,Mobility decreased,3,16470073
2,22.1,Palliative care,3,16470073
3,22.1,Metastases to liver,5,16470073
4,22.1,Prostate cancer,5,16470073
5,22.1,Asthenia,3,16470073
0,22.1,Death,5,16470125
1,22.1,Flushing,6,16470125
2,22.1,Dizziness,6,16470125
0,22.1,Colitis,1,16470140
0,22.0,Death,5,16470182
1,22.0,Asthenia,6,16470182
0,22.0,Acute abdomen,3,16470190
0,22.0,Stevens-Johnson syndrome,5,16470211
0,22.0,Dyspnoea,6,16470256
1,22.0,Cough,6,16470256
0,22.0,Hypertension,2,16470262
1,22.0,Death,5,16470262
2,22.0,Pain,3,16470262
0,22.1,Acute kidney injury,1,16470277
1,22.1,Pneumonia,1,16470277
0,22.0,Dysstasia,2,16470388
1,22.0,Muscular weakness,2,16470388
2,22.0,Muscle disorder,2,16470388
3,22.0,Hepatic enzyme increased,6,16470388
4,22.0,Fatigue,2,16470388
5,22.0,Paralysis,2,16470388
6,22.0,Sinusitis,6,16470388
7,22.0,Asthenia,2,16470388
8,22.0,Musculoskeletal stiffness,2,16470388
9,22.0,Movement disorder,2,16470388
0,22.0,Product use in unapproved indication,3,16470437
1,22.0,Abdominal pain,6,16470437
0,22.0,Renal impairment,6,16470506
0,22.0,Fatigue,6,16470521
1,22.0,Rash,6,16470521
2,22.0,Product use in unapproved indication,3,16470521
0,22.0,Vulvovaginal burning sensation,6,16470624
1,22.0,Seizure,6,16470624
2,22.0,Unresponsive to stimuli,6,16470624
3,22.0,Nausea,6,16470624
4,22.0,Dyspnoea,6,16470624
5,22.0,Discomfort,6,16470624
6,22.0,Burning sensation,6,16470624
7,22.0,Malaise,6,16470624
0,22.0,Ventricular fibrillation,1,16470625
0,22.0,Malignant neoplasm progression,1,16470673
1,22.0,Brain oedema,1,16470673
0,22.0,Suspected suicide,5,16470761
1,22.0,Intentional overdose,5,16470761
0,22.0,Tumour haemorrhage,6,16470791
1,22.0,Central nervous system haemorrhage,6,16470791
2,22.0,Rash,6,16470791
0,22.0,Death,5,16470800
1,22.0,Fall,6,16470800
2,22.0,Inappropriate schedule of product administration,6,16470800
3,22.0,Neck injury,6,16470800
0,22.0,Neurotoxicity,2,16470864
1,22.0,Delirium,2,16470864
2,22.0,Toxic encephalopathy,2,16470864
3,22.0,Discomfort,6,16470864
4,22.0,Dehydration,6,16470864
5,22.0,Restlessness,6,16470864
6,22.0,Myoclonus,6,16470864
7,22.0,Sleep disorder,6,16470864
8,22.0,Constipation,6,16470864
9,22.0,Serous cystadenocarcinoma ovary,5,16470864
10,22.0,Cancer pain,6,16470864
0,22.0,Dyspnoea,1,16470873
1,22.0,Depressive symptom,1,16470873
2,22.0,Headache,1,16470873
3,22.0,Hepatic pain,1,16470873
4,22.0,Paraesthesia,1,16470873
5,22.0,Blood pressure diastolic decreased,1,16470873
6,22.0,Fatigue,1,16470873
7,22.0,Hypotension,1,16470873
8,22.0,Treatment failure,1,16470873
9,22.0,Weight decreased,1,16470873
10,22.0,Platelet count decreased,1,16470873
11,22.0,Constipation,1,16470873
12,22.0,Hypoaesthesia,1,16470873
13,22.0,Nausea,1,16470873
14,22.0,Seizure,1,16470873
15,22.0,Blood pressure systolic decreased,1,16470873
16,22.0,Liver function test increased,1,16470873
17,22.0,Malaise,1,16470873
0,22.0,Off label use,6,16470878
1,22.0,"Hallucination, auditory",2,16470878
2,22.0,Product use issue,6,16470878
0,22.0,Metastases to liver,,16470981
1,22.0,Colon cancer,,16470981
2,22.0,Confusional state,,16470981
3,22.0,Dehydration,,16470981
4,22.0,Diarrhoea,6,16470981
5,22.0,Death,5,16470981
6,22.0,Hypersomnia,,16470981
7,22.0,Fatigue,,16470981
8,22.0,Ascites,,16470981
9,22.0,Food refusal,,16470981
10,22.0,Weight decreased,,16470981
11,22.0,Off label use,,16470981
0,22.0,Product use issue,6,16470997
1,22.0,General physical condition abnormal,6,16470997
2,22.0,Blood count abnormal,6,16470997
3,22.0,Discomfort,6,16470997
0,22.0,Multiple organ dysfunction syndrome,5,16471001
1,22.0,Malignant neoplasm progression,5,16471001
0,22.1,Hair colour changes,3,16471025
1,22.1,Madarosis,3,16471025
2,22.1,Hair disorder,3,16471025
3,22.1,Hair texture abnormal,3,16471025
4,22.1,Alopecia,3,16471025
0,22.0,Product use in unapproved indication,6,16471086
1,22.0,Rash pruritic,6,16471086
0,22.0,Cardio-respiratory arrest,5,16471096
0,22.1,Mitral valve incompetence,1,16471099
1,22.1,Alopecia,3,16471099
2,22.1,Weight decreased,6,16471099
3,22.1,Neutropenia,1,16471099
4,22.1,Electrocardiogram T wave abnormal,1,16471099
5,22.1,Aphasia,3,16471099
6,22.1,Eastern Cooperative Oncology Group performance status worsened,1,16471099
7,22.1,Nausea,3,16471099
0,22.0,Drug-induced liver injury,1,16471120
0,22.0,Blood creatine phosphokinase increased,1,16471125
1,22.0,Decreased appetite,1,16471125
0,22.0,Aspartate aminotransferase increased,6,16471158
1,22.0,Mucosal inflammation,6,16471158
2,22.0,Asthenia,6,16471158
3,22.0,Decreased appetite,6,16471158
4,22.0,Alanine aminotransferase increased,6,16471158
5,22.0,Jaw disorder,6,16471158
6,22.0,Death,5,16471158
7,22.0,Depressed mood,6,16471158
8,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16471158
9,22.0,Blood thyroid stimulating hormone increased,6,16471158
10,22.0,Sputum retention,6,16471158
11,22.0,Hypertension,6,16471158
0,22.0,No adverse event,6,16471161
0,22.0,Blister,1,16471162
1,22.0,Off label use,6,16471162
2,22.0,Lower respiratory tract infection,1,16471162
3,22.0,Death,5,16471162
4,22.0,Pain in extremity,1,16471162
0,22.0,Hyperkeratosis,3,16471163
1,22.0,Palmar-plantar erythrodysaesthesia syndrome,3,16471163
0,22.0,Nausea,6,16471179
1,22.0,Fatigue,6,16471179
2,22.0,Rash,6,16471179
3,22.0,Product use in unapproved indication,6,16471179
0,22.0,Product use in unapproved indication,6,16471181
1,22.0,Nausea,6,16471181
2,22.0,Fatigue,6,16471181
0,22.0,Assisted suicide,5,16471209
0,22.0,Pneumonia aspiration,2,16471258
0,22.0,Pyrexia,1,16471348
1,22.0,Abscess,1,16471348
2,22.0,Oesophageal perforation,1,16471348
3,22.0,Abdominal pain upper,1,16471348
4,22.0,Inflammation,1,16471348
5,22.0,Pleural effusion,1,16471348
0,22.0,Rash maculo-papular,1,16471370
1,22.0,Pyrexia,1,16471370
0,22.0,Fulminant type 1 diabetes mellitus,6,16471401
0,22.0,Disease progression,6,16471432
1,22.0,Malignant neoplasm progression,6,16471432
2,22.0,Drug resistance,6,16471432
3,22.0,Non-small cell lung cancer stage IIIA,6,16471432
4,22.0,EGFR gene mutation,6,16471432
0,22.0,Prostatic specific antigen increased,6,16471455
1,22.0,Metastases to spine,6,16471455
2,22.0,Disease progression,6,16471455
0,22.0,Lung neoplasm malignant,6,16471458
0,22.0,Blood urea increased,6,16471527
1,22.0,Diarrhoea,6,16471527
2,22.0,Radiation associated pain,6,16471527
3,22.0,Fatigue,6,16471527
4,22.0,Death,5,16471527
5,22.0,Nausea,1,16471527
6,22.0,Malaise,1,16471527
7,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16471527
0,22.0,Chest pain,6,16471528
0,22.0,Product use complaint,6,16471529
1,22.0,Death,5,16471529
2,22.0,Drug intolerance,6,16471529
0,22.1,Acute kidney injury,5,16471543
1,22.1,Gastrointestinal toxicity,5,16471543
0,22.0,Death,5,16471546
1,22.0,Brain stem infarction,3,16471546
0,22.0,Perforated ulcer,5,16471600
1,22.0,Malignant neoplasm progression,5,16471600
0,22.0,Alopecia,2,16471799
1,22.0,Madarosis,2,16471799
2,22.0,Hair texture abnormal,2,16471799
3,22.0,Hair colour changes,2,16471799
0,22.0,Death,5,16471835
0,22.0,Pyrexia,1,16471838
1,22.0,Erythema multiforme,1,16471838
0,22.1,Cytopenia,6,16471852
1,22.1,Balance disorder,6,16471852
2,22.1,Fatigue,6,16471852
0,22.0,Pruritus,6,16471867
1,22.0,Rash,6,16471867
2,22.0,Dizziness,6,16471867
3,22.0,Visual impairment,6,16471867
0,22.0,Flushing,1,16471880
1,22.0,Cold sweat,1,16471880
2,22.0,Eye movement disorder,1,16471880
3,22.0,Back pain,1,16471880
4,22.0,Chills,1,16471880
0,22.0,Sepsis,1,16471934
0,22.0,Emotional distress,6,16471940
1,22.0,Anxiety,6,16471940
2,22.0,Alopecia,6,16471940
0,22.0,Mental status changes,2,16471994
0,22.0,Oculomucocutaneous syndrome,2,16472085
0,22.0,Drug interaction,1,16472137
1,22.0,Hypoglycaemia,1,16472137
0,22.0,Product use in unapproved indication,6,16472145
1,22.0,Paraneoplastic neurological syndrome,6,16472145
0,22.0,Thinking abnormal,6,16472148
0,22.0,Death,5,16472203
0,22.0,Ejection fraction decreased,6,16472209
1,22.0,Cardiac failure,6,16472209
0,22.0,Bradycardia,1,16472236
0,22.0,Death,5,16472253
0,22.0,Muscle spasms,1,16472255
0,22.0,Breast enlargement,3,16472262
0,22.0,Depressed level of consciousness,2,16472277
1,22.0,Confusional state,2,16472277
2,22.0,Asthenia,2,16472277
3,22.0,Rash,6,16472277
4,22.0,Dry eye,6,16472277
5,22.0,Depression,6,16472277
6,22.0,Lung neoplasm malignant,3,16472277
7,22.0,Insomnia,6,16472277
0,22.1,Nausea,1,16472296
1,22.1,Vomiting,1,16472296
0,22.0,Terminal state,6,16472327
0,22.0,Liver injury,6,16472354
0,22.0,Second primary malignancy,6,16472439
0,22.0,Jaw disorder,6,16472440
1,22.0,Post procedural infection,6,16472440
0,22.0,Abdominal pain,1,16472467
1,22.0,Gastrointestinal necrosis,1,16472467
2,22.0,Bone marrow failure,1,16472467
3,22.0,Intestinal ischaemia,1,16472467
4,22.0,Blood pressure decreased,1,16472467
0,22.0,Abdominal pain,2,16472473
1,22.0,Bone marrow failure,6,16472473
2,22.0,Computerised tomogram abdomen abnormal,2,16472473
3,22.0,Vomiting,2,16472473
4,22.0,Blood pressure decreased,2,16472473
5,22.0,Intestinal ischaemia,2,16472473
0,22.0,Death,5,16472490
0,22.0,Death,5,16472497
0,22.1,Vomiting,6,16472547
1,22.1,Arthritis,6,16472547
2,22.1,Red blood cell count decreased,6,16472547
3,22.1,Nasal congestion,6,16472547
4,22.1,Joint warmth,2,16472547
5,22.1,Stress,6,16472547
6,22.1,Dry mouth,6,16472547
7,22.1,White blood cell count decreased,6,16472547
8,22.1,Asthenia,2,16472547
9,22.1,Basal cell carcinoma,6,16472547
10,22.1,Oral pain,6,16472547
11,22.1,Joint swelling,2,16472547
12,22.1,Blood glucose increased,6,16472547
13,22.1,Gastrooesophageal reflux disease,6,16472547
14,22.1,Carbohydrate antigen 125 increased,6,16472547
15,22.1,Laboratory test abnormal,6,16472547
16,22.1,Underdose,6,16472547
17,22.1,Cataract,6,16472547
18,22.1,Blood test abnormal,6,16472547
19,22.1,Dyspepsia,3,16472547
20,22.1,Haematocrit decreased,6,16472547
21,22.1,Nausea,1,16472547
22,22.1,Product dose omission,6,16472547
23,22.1,Dehydration,6,16472547
24,22.1,Sinus disorder,3,16472547
25,22.1,Feeling abnormal,3,16472547
26,22.1,Haemoglobin decreased,6,16472547
27,22.1,Fatigue,3,16472547
28,22.1,Decreased appetite,6,16472547
29,22.1,Constipation,3,16472547
0,22.0,Death,5,16472557
0,22.0,Death,5,16472578
0,22.0,Ototoxicity,2,16472586
0,22.0,Vomiting,3,16472589
0,22.0,Death,5,16472594
0,22.0,Prostatic specific antigen increased,1,16472612
1,22.0,Cardiac disorder,1,16472612
2,22.0,Pulmonary oedema,1,16472612
3,22.0,Abdominal distension,1,16472612
4,22.0,Waist circumference increased,1,16472612
5,22.0,Dyspnoea,1,16472612
0,22.0,Bursitis,2,16472621
1,22.0,Neutrophil count increased,3,16472621
2,22.0,Rash,2,16472621
3,22.0,Skin mass,2,16472621
4,22.0,Muscular weakness,2,16472621
5,22.0,Pneumonia,6,16472621
6,22.0,Feeling abnormal,3,16472621
7,22.0,Chills,1,16472621
8,22.0,Exercise tolerance decreased,6,16472621
9,22.0,Vomiting,3,16472621
10,22.0,Malaise,6,16472621
11,22.0,Lymphadenopathy,1,16472621
12,22.0,Prostate cancer stage IV,3,16472621
13,22.0,Loss of consciousness,1,16472621
14,22.0,Neutropenia,1,16472621
15,22.0,White blood cell count abnormal,6,16472621
16,22.0,Cough,3,16472621
17,22.0,Fatigue,3,16472621
18,22.0,Vertigo,6,16472621
19,22.0,Axillary mass,1,16472621
20,22.0,Haemoglobin decreased,1,16472621
21,22.0,Squamous cell carcinoma of skin,2,16472621
22,22.0,Prostatic specific antigen increased,3,16472621
23,22.0,Chronic lymphocytic leukaemia,2,16472621
24,22.0,Oropharyngeal pain,2,16472621
25,22.0,Depressed mood,2,16472621
26,22.0,Hormone-refractory prostate cancer,3,16472621
27,22.0,Malaise,1,16472621
28,22.0,Blood glucose increased,3,16472621
29,22.0,Nausea,1,16472621
30,22.0,Nasopharyngitis,3,16472621
31,22.0,Pallor,6,16472621
32,22.0,Poor quality sleep,2,16472621
33,22.0,Dyspnoea,6,16472621
34,22.0,Fungal skin infection,1,16472621
35,22.0,Dyspnoea,2,16472621
36,22.0,Blood pressure decreased,1,16472621
37,22.0,Lymphocyte count decreased,3,16472621
38,22.0,Myalgia,2,16472621
39,22.0,Tremor,3,16472621
40,22.0,Infection,3,16472621
41,22.0,Red blood cell count increased,6,16472621
0,22.0,Renal failure,2,16472652
1,22.0,Bicytopenia,1,16472652
2,22.0,Neutropenia,1,16472652
0,22.0,Scrotal pain,1,16472675
1,22.0,Acute myocardial infarction,6,16472675
2,22.0,Scrotal haematoma,1,16472675
3,22.0,Scrotal swelling,1,16472675
4,22.0,Orchitis,1,16472675
5,22.0,Scrotal abscess,1,16472675
6,22.0,Epididymitis,1,16472675
7,22.0,Abscess drainage,1,16472675
0,22.0,Death,5,16472689
0,22.0,Stomatitis,2,16472695
0,22.0,Chills,1,16472702
1,22.0,Diarrhoea,1,16472702
2,22.0,Tachypnoea,1,16472702
3,22.0,Flushing,1,16472702
4,22.0,Vomiting,1,16472702
5,22.0,Nausea,1,16472702
6,22.0,Dyspnoea,1,16472702
0,22.0,Polyneuropathy,2,16472724
0,22.0,Influenza virus test positive,6,16472739
1,22.0,Malignant neoplasm progression,5,16472739
2,22.0,Pyrexia,6,16472739
3,22.0,Demyelination,3,16472739
0,22.0,Pneumonitis,6,16472741
1,22.0,Headache,6,16472741
2,22.0,Tachypnoea,6,16472741
3,22.0,Pleural effusion,6,16472741
4,22.0,Productive cough,6,16472741
5,22.0,Cough,6,16472741
6,22.0,Lung infection,6,16472741
7,22.0,Pneumonia,6,16472741
0,22.0,Death,5,16472757
0,22.0,Off label use,6,16472768
1,22.0,Death,5,16472768
0,22.0,Death,5,16472799
0,22.0,Death,5,16472800
0,22.0,Leukoerythroblastosis,6,16472805
1,22.0,Treatment failure,6,16472805
2,22.0,Thrombocytopenia,6,16472805
3,22.0,Blood albumin decreased,6,16472805
4,22.0,Pulmonary oedema,6,16472805
5,22.0,Multiple organ dysfunction syndrome,5,16472805
6,22.0,Adenocarcinoma,6,16472805
7,22.0,Disseminated intravascular coagulation,6,16472805
8,22.0,Normocytic anaemia,6,16472805
9,22.0,Blood calcium decreased,6,16472805
10,22.0,Blood alkaline phosphatase increased,6,16472805
0,22.0,Hypokalaemia,6,16472821
1,22.0,Sepsis,6,16472821
2,22.0,Hypoalbuminaemia,6,16472821
3,22.0,Nausea,6,16472821
4,22.0,Dyspepsia,6,16472821
5,22.0,Peripheral sensory neuropathy,6,16472821
6,22.0,Thrombocytopenia,6,16472821
7,22.0,Blood alkaline phosphatase increased,6,16472821
8,22.0,Stomatitis,6,16472821
9,22.0,Decreased appetite,6,16472821
10,22.0,Rash,6,16472821
11,22.0,Hypoaesthesia,6,16472821
12,22.0,Blood creatinine increased,6,16472821
13,22.0,Myalgia,6,16472821
14,22.0,Hyperbilirubinaemia,6,16472821
15,22.0,Leukopenia,6,16472821
16,22.0,Fatigue,6,16472821
17,22.0,Blood urea increased,6,16472821
18,22.0,Hyponatraemia,6,16472821
19,22.0,Ejection fraction decreased,6,16472821
20,22.0,Diarrhoea,6,16472821
21,22.0,Alanine aminotransferase increased,6,16472821
22,22.0,Anaemia,6,16472821
23,22.0,Neutropenia,6,16472821
24,22.0,Aspartate aminotransferase increased,6,16472821
25,22.0,Malaise,6,16472821
0,22.0,Insomnia,6,16472835
1,22.0,Arthritis,6,16472835
2,22.0,Bone pain,6,16472835
0,22.0,Lymphoedema,6,16472893
1,22.0,Chylothorax,2,16472893
2,22.0,Oedema,6,16472893
3,22.0,Ascites,2,16472893
4,22.0,Pleural effusion,2,16472893
5,22.0,Proteinuria,6,16472893
6,22.0,Limb injury,6,16472893
0,22.0,Renal impairment,6,16472920
1,22.0,Diarrhoea,6,16472920
2,22.0,Hypocalcaemia,6,16472920
3,22.0,Tooth disorder,6,16472920
4,22.0,Dental operation,6,16472920
5,22.0,Impaired healing,6,16472920
6,22.0,Hypercalcaemia,6,16472920
0,22.0,Polyneuropathy,2,16472924
0,22.0,Myalgia,2,16472940
1,22.0,Bone pain,2,16472940
2,22.0,Arthralgia,2,16472940
0,22.1,Aortitis,1,16472945
0,22.0,Anxiety,1,16472974
1,22.0,Dyspnoea,1,16472974
2,22.0,Tachycardia,1,16472974
3,22.0,Erythema,1,16472974
0,22.0,Neoplasm,6,16472999
1,22.0,Constipation,1,16472999
2,22.0,Diarrhoea,1,16472999
3,22.0,Metastases to bone,6,16472999
4,22.0,Fatigue,3,16472999
5,22.0,Femur fracture,6,16472999
6,22.0,Pain,6,16472999
7,22.0,Diarrhoea,6,16472999
8,22.0,Ilium fracture,6,16472999
0,22.0,Diarrhoea,1,16473073
1,22.0,Clostridial infection,1,16473073
0,22.0,Anaphylactic shock,1,16473104
0,22.0,Upper limb fracture,2,16473207
1,22.0,Fall,2,16473207
0,22.0,Infection,5,16473236
0,22.0,Food allergy,6,16473246
1,22.0,Vomiting,6,16473246
0,22.0,Neutrophilia,6,16473248
1,22.0,Off label use,6,16473248
2,22.0,Dysstasia,6,16473248
3,22.0,Tachycardia,6,16473248
4,22.0,Intentional product use issue,6,16473248
5,22.0,Normochromic anaemia,6,16473248
6,22.0,Lymphadenopathy,6,16473248
7,22.0,Gait disturbance,6,16473248
8,22.0,Pulmonary toxicity,6,16473248
9,22.0,C-reactive protein increased,6,16473248
10,22.0,Hypotension,6,16473248
11,22.0,Lymphocytosis,6,16473248
12,22.0,Cough,6,16473248
13,22.0,Pyrexia,6,16473248
14,22.0,Muscular weakness,6,16473248
15,22.0,Fatigue,6,16473248
16,22.0,Interstitial lung disease,2,16473248
0,22.0,Prostatic specific antigen increased,3,16473250
0,22.0,Death,5,16473296
0,22.0,Nausea,6,16473342
1,22.0,Oral pain,3,16473342
2,22.0,Decreased appetite,2,16473342
3,22.0,Vomiting,6,16473342
0,22.0,Metastases to central nervous system,2,16473384
1,22.0,Vasogenic cerebral oedema,2,16473384
2,22.0,Pneumonitis,6,16473384
0,22.0,Intestinal obstruction,6,16473387
1,22.0,Lymphadenitis,6,16473387
2,22.0,Interstitial lung disease,6,16473387
3,22.0,Hepatic steatosis,6,16473387
0,22.0,Trigger finger,6,16473404
1,22.0,Sleep disorder,6,16473404
2,22.0,Weight increased,6,16473404
3,22.0,Blood pressure increased,6,16473404
4,22.0,Eye irritation,6,16473404
5,22.0,Micturition urgency,6,16473404
6,22.0,Palpitations,6,16473404
7,22.0,Pain in extremity,6,16473404
8,22.0,Sensory disturbance,6,16473404
9,22.0,Joint swelling,6,16473404
10,22.0,Breast pain,6,16473404
11,22.0,Bone pain,6,16473404
12,22.0,Hot flush,6,16473404
13,22.0,Arthralgia,6,16473404
14,22.0,Impaired quality of life,6,16473404
15,22.0,Dry mouth,6,16473404
16,22.0,Vision blurred,6,16473404
17,22.0,Dry skin,6,16473404
18,22.0,Alopecia,6,16473404
0,22.0,Death,5,16473417
0,22.1,Osteonecrosis,6,16473426
1,22.1,Dyspnoea exertional,6,16473426
2,22.1,Hypersomnia,6,16473426
3,22.1,Neoplasm progression,6,16473426
4,22.1,Asthenia,6,16473426
5,22.1,Loss of personal independence in daily activities,6,16473426
6,22.1,Fatigue,6,16473426
0,22.0,Neoplasm progression,6,16473430
1,22.0,Arthralgia,6,16473430
2,22.0,Anxiety,6,16473430
3,22.0,Peripheral swelling,6,16473430
4,22.0,Back pain,6,16473430
5,22.0,Urosepsis,6,16473430
6,22.0,Nervousness,6,16473430
7,22.0,Fatigue,6,16473430
0,22.1,Blindness,3,16473445
1,22.1,Death,5,16473445
0,22.0,Atrioventricular block second degree,3,16473476
0,22.0,Bicytopenia,1,16473498
1,22.0,Anaemia,1,16473498
0,22.0,Acute kidney injury,2,16473609
1,22.0,Pancytopenia,2,16473609
0,22.0,Leukopenia,6,16473612
1,22.0,Neutropenia,6,16473612
2,22.0,Febrile neutropenia,6,16473612
3,22.0,Anaemia,6,16473612
0,22.0,Platelet count decreased,6,16473622
1,22.0,Neutrophil count decreased,6,16473622
2,22.0,Hepatic function abnormal,6,16473622
0,22.0,Hypokalaemia,6,16473669
1,22.0,Adrenal insufficiency,6,16473669
2,22.0,Hypothyroidism,6,16473669
0,22.0,Hepatitis,3,16473722
0,22.0,Paraesthesia,1,16473736
1,22.0,Hypersensitivity,1,16473736
2,22.0,Hypotension,1,16473736
0,22.0,Pulmonary embolism,3,16473751
0,22.0,Tubulointerstitial nephritis,3,16473789
0,22.0,Nausea,6,16473811
1,22.0,Chest pain,6,16473811
2,22.0,Bone pain,6,16473811
3,22.0,Leukopenia,6,16473811
4,22.0,Vomiting,6,16473811
5,22.0,Bone marrow failure,6,16473811
6,22.0,Neutropenia,6,16473811
7,22.0,Stomatitis,6,16473811
8,22.0,Fatigue,6,16473811
0,22.0,Off label use,6,16473827
1,22.0,Renal failure,6,16473827
2,22.0,Death,5,16473827
0,22.0,Tremor,6,16473833
1,22.0,Ventricular fibrillation,5,16473833
2,22.0,Seizure,6,16473833
3,22.0,Hepatic function abnormal,6,16473833
4,22.0,Ventricular fibrillation,6,16473833
5,22.0,Death,5,16473833
6,22.0,Nausea,6,16473833
7,22.0,Pyrexia,6,16473833
0,22.0,Palpitations,1,16473834
1,22.0,Rash,1,16473834
2,22.0,Chest discomfort,1,16473834
0,22.0,Malignant neoplasm progression,6,16473845
0,22.0,Confusional state,6,16473849
1,22.0,Ataxia,6,16473849
2,22.0,Blood thyroid stimulating hormone increased,6,16473849
3,22.0,Metastases to central nervous system,5,16473849
4,22.0,Orthostatic hypotension,6,16473849
5,22.0,Malignant neoplasm progression,5,16473849
6,22.0,Hypertension,6,16473849
0,22.0,Death,5,16473899
0,22.0,Condition aggravated,5,16473940
0,22.0,Cholangitis,1,16474040
1,22.0,Blood alkaline phosphatase increased,1,16474040
2,22.0,Large intestinal stenosis,1,16474040
3,22.0,Pyrexia,1,16474040
0,22.1,Back pain,2,16474083
1,22.1,Dyspnoea,2,16474083
2,22.1,Fatigue,2,16474083
3,22.1,Heart rate increased,2,16474083
4,22.1,Urinary tract infection,2,16474083
5,22.1,Asthenia,3,16474083
6,22.1,Alopecia,6,16474083
0,22.0,Fatigue,6,16474096
0,22.0,Neoplasm progression,6,16474099
0,22.1,Hypoacusis,3,16474102
0,22.1,Loss of personal independence in daily activities,6,16474107
1,22.1,Herpes zoster,6,16474107
2,22.1,Gait disturbance,6,16474107
3,22.1,Dry skin,6,16474107
4,22.1,White blood cell count decreased,6,16474107
0,22.0,Fatigue,6,16474121
1,22.0,Alopecia,6,16474121
0,22.1,Anxiety,6,16474136
0,22.1,Dyspnoea,2,16474139
1,22.1,Malaise,2,16474139
2,22.1,Poor quality product administered,6,16474139
3,22.1,Neoplasm progression,3,16474139
4,22.1,Pleural effusion,6,16474139
5,22.1,Fatigue,2,16474139
6,22.1,Product storage error,6,16474139
0,22.0,Arthralgia,,16474226
0,22.0,Gastrointestinal necrosis,5,16474253
1,22.0,Neutropenic colitis,5,16474253
0,22.0,Diarrhoea,3,16474257
1,22.0,Neoplasm progression,3,16474257
2,22.0,Nausea,3,16474257
0,22.0,Neoplasm progression,6,16474259
0,22.0,Confusional state,6,16474282
1,22.0,Small intestinal obstruction,6,16474282
2,22.0,Memory impairment,6,16474282
0,22.0,Decreased appetite,6,16474301
1,22.0,Fatigue,6,16474301
2,22.0,White blood cell count decreased,6,16474301
3,22.0,Anaemia,6,16474301
4,22.0,Feeling cold,6,16474301
5,22.0,Malaise,6,16474301
6,22.0,Taste disorder,6,16474301
7,22.0,Disability,6,16474301
8,22.0,Ill-defined disorder,6,16474301
0,22.0,Pyrexia,1,16474358
1,22.0,Productive cough,1,16474358
2,22.0,Leukopenia,1,16474358
0,22.0,Blood pressure increased,,16474382
1,22.0,Diarrhoea,,16474382
2,22.0,Insomnia,,16474382
0,22.0,Metastatic gastric cancer,5,16474398
0,22.0,Nausea,,16474404
1,22.0,Dyspepsia,,16474404
0,22.0,Bone tuberculosis,6,16474407
0,22.0,Hernia repair,6,16474411
1,22.0,Bladder operation,6,16474411
0,22.0,Neurotoxicity,2,16474423
0,22.0,Arrhythmia,1,16474433
1,22.0,Cardiac arrest,1,16474433
2,22.0,Left ventricular dysfunction,1,16474433
0,22.0,Back pain,,16474458
0,22.0,Acute kidney injury,1,16474461
0,22.0,Disease progression,,16474462
0,22.0,Disease progression,,16474477
0,22.0,Disease progression,,16474499
0,22.0,Dysgeusia,6,16474523
1,22.0,Gastrointestinal disorder,6,16474523
2,22.0,Nausea,1,16474523
3,22.0,Vomiting,3,16474523
4,22.0,Vomiting,1,16474523
5,22.0,Diarrhoea,1,16474523
6,22.0,Nausea,3,16474523
7,22.0,Intestinal obstruction,6,16474523
8,22.0,Weight increased,6,16474523
9,22.0,Abdominal pain,6,16474523
10,22.0,Product dose omission,6,16474523
11,22.0,Diarrhoea,3,16474523
12,22.0,Fatigue,3,16474523
0,22.0,Myocardial infarction,6,16474527
1,22.0,Blood test abnormal,6,16474527
2,22.0,Electrocardiogram QT prolonged,6,16474527
3,22.0,Sinus bradycardia,6,16474527
4,22.0,Electrocardiogram QRS complex prolonged,6,16474527
0,22.0,Death,5,16474533
0,22.0,Fatigue,,16474541
1,22.0,White blood cell count decreased,,16474541
0,22.0,Neuropathy peripheral,,16474579
0,22.0,Neuropathy peripheral,,16474586
0,22.0,Malignant gastrointestinal obstruction,6,16474587
0,22.0,Malaise,2,16474595
1,22.0,Pneumonia,2,16474595
2,22.0,Mobility decreased,2,16474595
0,22.0,Blood urine present,,16474598
0,22.0,Hepatic failure,5,16474600
1,22.0,Hepatic cirrhosis,5,16474600
0,22.0,Orchitis,3,16474610
0,22.1,Cerebral infarction,6,16474624
0,22.0,Interstitial lung disease,1,16474632
1,22.0,Infection,5,16474632
2,22.0,Pneumonia,5,16474632
0,22.1,Hair colour changes,3,16474651
1,22.1,Alopecia,6,16474651
2,22.1,Hair disorder,3,16474651
3,22.1,Hair texture abnormal,3,16474651
4,22.1,Mental disorder,6,16474651
0,22.0,Neuropathy peripheral,3,16474697
1,22.0,Off label use,,16474697
2,22.0,Oropharyngeal pain,3,16474697
0,22.0,Nausea,,16474767
1,22.0,Vomiting,,16474767
2,22.0,Dehydration,,16474767
3,22.0,Therapy cessation,,16474767
4,22.0,Free prostate-specific antigen increased,,16474767
0,22.0,Pneumonitis,5,16474783
1,22.0,Cough,5,16474783
2,22.0,Dyspnoea,5,16474783
3,22.0,Alveolitis,5,16474783
0,22.0,Vomiting,3,16474845
1,22.0,Nausea,6,16474845
2,22.0,Death,5,16474845
3,22.0,Malaise,6,16474845
0,22.0,Deep vein thrombosis,6,16474872
1,22.0,Mucosal inflammation,2,16474872
0,22.1,Barrett^s oesophagus,6,16474907
1,22.1,Joint swelling,1,16474907
2,22.1,Rectal haemorrhage,1,16474907
3,22.1,Peripheral swelling,1,16474907
4,22.1,Nausea,2,16474907
5,22.1,Duodenitis,6,16474907
6,22.1,Peripheral vascular disorder,1,16474907
7,22.1,Joint warmth,6,16474907
8,22.1,Limb discomfort,3,16474907
9,22.1,Decreased appetite,3,16474907
10,22.1,Fatigue,3,16474907
11,22.1,Gastroenteritis viral,2,16474907
12,22.1,Visual impairment,3,16474907
13,22.1,Faeces hard,1,16474907
14,22.1,Back pain,3,16474907
15,22.1,Weight decreased,3,16474907
16,22.1,Diverticulum intestinal,6,16474907
17,22.1,Thrombocytopenia,6,16474907
18,22.1,Duodenal ulcer,6,16474907
19,22.1,Paraesthesia,6,16474907
20,22.1,Nocturia,3,16474907
21,22.1,Constipation,3,16474907
22,22.1,Asthenia,6,16474907
23,22.1,Gastritis,6,16474907
0,22.0,Bacteraemia,1,16474945
0,22.0,Death,5,16474955
0,22.0,Neutropenia,6,16474984
0,22.0,Death,5,16474994
0,22.0,Intentional overdose,5,16475007
1,22.0,Suspected suicide,5,16475007
0,22.0,Pulmonary embolism,6,16475008
1,22.0,Neuropathy peripheral,6,16475008
2,22.0,Fatigue,6,16475008
0,22.0,Product use in unapproved indication,6,16475010
1,22.0,Death,5,16475010
2,22.0,Off label use,6,16475010
0,22.0,Neoplasm progression,5,16475011
1,22.0,Confusional state,3,16475011
2,22.0,Hepatic failure,5,16475011
0,22.0,Vomiting,6,16475016
1,22.0,Dehydration,6,16475016
2,22.0,Disease progression,3,16475016
3,22.0,Hypophagia,6,16475016
0,22.0,Death,5,16475052
0,22.0,Haematuria,6,16475068
1,22.0,Interstitial lung disease,5,16475068
2,22.0,Acute respiratory failure,5,16475068
3,22.0,Antiphospholipid syndrome,5,16475068
4,22.0,Deep vein thrombosis,6,16475068
5,22.0,Pulmonary alveolar haemorrhage,5,16475068
6,22.0,Diffuse alveolar damage,5,16475068
0,22.0,Hypoaesthesia,3,16475080
1,22.0,Paraesthesia,3,16475080
2,22.0,Neuropathy peripheral,3,16475080
0,22.0,Hepatocellular injury,1,16475086
1,22.0,Hepatic enzyme increased,1,16475086
0,22.0,Malignant neoplasm progression,5,16475099
1,22.0,Drug ineffective for unapproved indication,6,16475099
0,22.0,Malignant neoplasm progression,6,16475106
1,22.0,Myalgia,6,16475106
2,22.0,Pruritus,6,16475106
3,22.0,Thyroid disorder,6,16475106
4,22.0,Pruritus generalised,6,16475106
5,22.0,Rash generalised,6,16475106
6,22.0,Muscle spasms,6,16475106
0,22.0,Oral infection,6,16475410
1,22.0,Tooth loss,6,16475410
2,22.0,Osteonecrosis of jaw,3,16475410
3,22.0,Toothache,6,16475410
0,22.0,Euthanasia,5,16475419
1,22.0,Weight increased,6,16475419
0,22.0,Malignant pleural effusion,1,16475457
0,22.0,Hypertension,3,16475484
1,22.0,Anxiety,3,16475484
0,22.0,Pain in extremity,3,16475504
0,22.1,Interstitial lung disease,2,16475528
1,22.1,Sjogren^s syndrome,6,16475528
2,22.1,Interstitial lung disease,2,16475528
0,22.0,Chronic obstructive pulmonary disease,,16475530
1,22.0,Respiratory tract infection,,16475530
0,22.0,Metastases to liver,3,16475532
1,22.0,Hormone-refractory prostate cancer,3,16475532
0,22.0,Polyneuropathy,2,16475536
0,22.0,Sepsis,,16475538
1,22.0,Genitourinary tract infection,,16475538
2,22.0,Haematology test abnormal,,16475538
0,22.0,Blister,,16475564
0,22.0,Vomiting,5,16475587
1,22.0,Malignant neoplasm progression,5,16475587
2,22.0,Overdose,5,16475587
3,22.0,Abdominal pain,5,16475587
4,22.0,Nausea,5,16475587
5,22.0,Metastatic gastric cancer,5,16475587
6,22.0,Product use in unapproved indication,5,16475587
7,22.0,Hypophagia,5,16475587
8,22.0,Drug ineffective,5,16475587
9,22.0,Ascites,5,16475587
10,22.0,Pain,5,16475587
0,22.0,Dizziness,,16475603
1,22.0,Tinnitus,,16475603
2,22.0,Bone marrow failure,,16475603
3,22.0,Hepatic function abnormal,,16475603
4,22.0,Oedema peripheral,,16475603
5,22.0,Chills,,16475603
0,22.1,Joint injury,6,16475627
0,22.0,Peripheral nerve injury,6,16475649
1,22.0,Dizziness,6,16475649
2,22.0,Anxiety,6,16475649
3,22.0,Nervousness,3,16475649
4,22.0,Lacrimation increased,6,16475649
5,22.0,Nasopharyngitis,6,16475649
6,22.0,Fatigue,6,16475649
7,22.0,Impaired quality of life,6,16475649
8,22.0,Gastrointestinal disorder,6,16475649
9,22.0,Pruritus,6,16475649
10,22.0,Diarrhoea,2,16475649
11,22.0,Abdominal pain upper,1,16475649
12,22.0,Feeling abnormal,6,16475649
13,22.0,Somnolence,6,16475649
14,22.0,Hot flush,6,16475649
15,22.0,Biliary colic,6,16475649
16,22.0,Pain in extremity,3,16475649
17,22.0,Constipation,6,16475649
18,22.0,Nausea,3,16475649
19,22.0,Irritable bowel syndrome,6,16475649
20,22.0,Restless legs syndrome,6,16475649
21,22.0,Asthenia,3,16475649
22,22.0,Drug ineffective,6,16475649
0,22.0,Proteinuria,6,16475678
0,22.0,Hair colour changes,3,16475680
1,22.0,Hair disorder,3,16475680
2,22.0,Alopecia,3,16475680
3,22.0,Hair texture abnormal,3,16475680
0,22.0,Neoplasm progression,6,16475689
1,22.0,Full blood count decreased,6,16475689
2,22.0,Fatigue,6,16475689
3,22.0,Gastrointestinal disorder,6,16475689
4,22.0,Neutropenia,6,16475689
0,22.1,Alopecia,3,16475692
1,22.1,Hair colour changes,3,16475692
2,22.1,Hair disorder,3,16475692
3,22.1,Madarosis,3,16475692
4,22.1,Hair texture abnormal,3,16475692
0,22.0,Alopecia,3,16475693
1,22.0,Madarosis,3,16475693
0,22.1,Hair colour changes,3,16475695
1,22.1,Madarosis,3,16475695
2,22.1,Hair disorder,3,16475695
3,22.1,Alopecia,3,16475695
4,22.1,Hair texture abnormal,3,16475695
0,22.0,Amnesia,4,16475751
0,22.1,Haemoptysis,5,16475763
1,22.1,Acute respiratory failure,5,16475763
2,22.1,Interstitial lung disease,5,16475763
3,22.1,Cerebral infarction,6,16475763
4,22.1,Liver disorder,6,16475763
0,22.0,Death,5,16475845
0,22.0,Death,5,16475846
1,22.0,Off label use,6,16475846
0,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16475847
1,22.0,Stomatitis,6,16475847
2,22.0,Malignant neoplasm progression,6,16475847
3,22.0,Campylobacter infection,6,16475847
4,22.0,Guillain-Barre syndrome,5,16475847
5,22.0,Diarrhoea,6,16475847
6,22.0,Asthenia,6,16475847
0,22.0,Death,5,16475849
1,22.0,Vomiting,6,16475849
2,22.0,Nasopharyngitis,6,16475849
0,22.0,Death,5,16475850
1,22.0,Dyspnoea,6,16475850
0,22.0,Death,5,16475852
0,22.0,Nasal congestion,1,16475870
1,22.0,Tumour marker increased,2,16475870
2,22.0,Abdominal pain upper,2,16475870
3,22.0,Nasopharyngitis,1,16475870
4,22.0,White blood cell count decreased,3,16475870
5,22.0,Multiple organ dysfunction syndrome,6,16475870
6,22.0,Death,5,16475870
7,22.0,Nausea,3,16475870
0,22.0,Portal vein dilatation,1,16475875
1,22.0,Disseminated Bacillus Calmette-Guerin infection,1,16475875
2,22.0,Liver injury,1,16475875
3,22.0,Pyrexia,1,16475875
4,22.0,Bladder cancer,6,16475875
5,22.0,Hepatitis,1,16475875
0,22.0,Interstitial lung disease,2,16475949
0,22.0,Pneumocystis jirovecii pneumonia,1,16475963
1,22.0,Pancytopenia,2,16475963
0,22.0,Malignant neoplasm progression,6,16475970
1,22.0,Metastases to liver,6,16475970
0,22.0,Acne,6,16476010
1,22.0,Product use in unapproved indication,6,16476010
0,22.0,Vomiting,6,16476013
1,22.0,Product use in unapproved indication,6,16476013
0,22.0,Hyperkalaemia,1,16476036
1,22.0,Acute kidney injury,1,16476036
2,22.0,Cardio-respiratory arrest,1,16476036
3,22.0,Metabolic acidosis,1,16476036
0,22.0,Fall,6,16476042
1,22.0,Hypokalaemia,6,16476042
0,22.0,Subarachnoid haemorrhage,5,16476058
0,22.0,Adverse event,6,16476061
0,22.0,Rash,3,16476080
0,22.1,Pneumonitis,2,16476093
0,22.0,Death,5,16476101
0,22.0,Death,5,16476206
0,22.0,Proteinuria,6,16476214
1,22.0,Oedema peripheral,6,16476214
2,22.0,Ascites,6,16476214
3,22.0,Therapy partial responder,6,16476214
4,22.0,Skin erosion,6,16476214
5,22.0,Disease progression,6,16476214
6,22.0,Lymphoedema,6,16476214
0,22.0,Abdominal pain,1,16476271
1,22.0,Blood pressure decreased,1,16476271
2,22.0,Erythema,1,16476271
3,22.0,Dyspnoea,1,16476271
4,22.0,Altered state of consciousness,1,16476271
5,22.0,Malaise,1,16476271
0,22.0,Extravasation,2,16476272
0,22.1,Intracranial tumour haemorrhage,5,16476300
0,22.1,Vomiting,2,16476329
1,22.1,Interstitial lung disease,5,16476329
0,22.0,Diarrhoea,1,16476344
1,22.0,Clostridial infection,1,16476344
2,22.0,Off label use,6,16476344
0,22.0,Carbohydrate antigen 125 increased,6,16476351
0,22.0,Prostate cancer,6,16476357
1,22.0,Prostatic specific antigen increased,6,16476357
0,22.0,Acute kidney injury,4,16476422
1,22.0,Haemoglobin decreased,6,16476422
0,22.0,Coronary artery disease,5,16476431
0,22.0,Osteonecrosis,1,16476497
0,22.0,Disease progression,3,16476499
1,22.0,Insomnia,3,16476499
2,22.0,Mucosal inflammation,3,16476499
3,22.0,Dermatitis acneiform,3,16476499
4,22.0,Skin irritation,1,16476499
5,22.0,Hyperaesthesia teeth,3,16476499
6,22.0,Back pain,3,16476499
7,22.0,Abdominal pain,6,16476499
8,22.0,Weight decreased,3,16476499
9,22.0,Neuropathy peripheral,6,16476499
10,22.0,Diarrhoea,3,16476499
11,22.0,Acne,3,16476499
12,22.0,Anorectal discomfort,3,16476499
13,22.0,Burning sensation,1,16476499
14,22.0,Chapped lips,3,16476499
15,22.0,Furuncle,3,16476499
16,22.0,Nail disorder,3,16476499
0,22.0,Intentional product use issue,6,16476516
1,22.0,Off label use,6,16476516
2,22.0,Pulmonary haemorrhage,6,16476516
0,22.0,Head banging,6,16476627
1,22.0,Vertebrobasilar insufficiency,1,16476627
2,22.0,Hypersensitivity,6,16476627
3,22.0,Fall,6,16476627
0,22.0,Platelet count decreased,6,16476637
1,22.0,Malaise,6,16476637
2,22.0,Renal impairment,6,16476637
3,22.0,Diarrhoea,2,16476637
0,22.0,Enteritis,1,16476651
0,22.0,Decreased activity,2,16476661
0,22.0,Dyspnoea,1,16476667
1,22.0,Mydriasis,1,16476667
2,22.0,Dyskinesia,1,16476667
3,22.0,Hypotension,1,16476667
4,22.0,Rash,1,16476667
5,22.0,Loss of consciousness,1,16476667
0,22.1,Wound secretion,3,16476722
1,22.1,Duodenal ulcer perforation,3,16476722
2,22.1,Fistula,6,16476722
0,22.0,Hypertension,1,16476739
1,22.0,Pallor,1,16476739
2,22.0,Tremor,1,16476739
3,22.0,Nasopharyngitis,1,16476739
4,22.0,Arthralgia,1,16476739
5,22.0,Suspected counterfeit product,6,16476739
0,22.0,General physical health deterioration,1,16476789
1,22.0,Product use issue,6,16476789
2,22.0,Incorrect dose administered,6,16476789
0,22.0,Cholestasis,6,16476835
0,22.0,Product supply issue,6,16476852
1,22.0,Product availability issue,6,16476852
2,22.0,Bladder cancer recurrent,6,16476852
0,22.1,Flushing,1,16476883
1,22.1,Pruritus,1,16476883
2,22.1,Abdominal pain upper,1,16476883
0,22.0,Disseminated tuberculosis,2,16476889
1,22.0,Pyrexia,6,16476889
2,22.0,Granulomatous pneumonitis,2,16476889
3,22.0,Disseminated Bacillus Calmette-Guerin infection,2,16476889
0,22.0,Fatigue,1,16476892
1,22.0,Dysgeusia,1,16476892
2,22.0,Dysphagia,1,16476892
3,22.0,Dysaesthesia,6,16476892
4,22.0,Hypokalaemia,1,16476892
5,22.0,Palmar-plantar erythrodysaesthesia syndrome,1,16476892
6,22.0,Nausea,1,16476892
7,22.0,Performance status decreased,1,16476892
8,22.0,Dysgeusia,1,16476892
9,22.0,Diarrhoea,1,16476892
10,22.0,Diarrhoea,1,16476892
11,22.0,Febrile neutropenia,1,16476892
12,22.0,Nausea,6,16476892
0,22.0,Death,5,16477016
0,22.0,Death,5,16477086
1,22.0,Breast cancer metastatic,6,16477086
0,22.0,Product dose omission,6,16477091
1,22.0,Abdominal pain upper,6,16477091
2,22.0,Death,5,16477091
3,22.0,Fatigue,6,16477091
0,22.0,Acute myeloid leukaemia,3,16477108
0,22.0,Emotional distress,6,16477128
1,22.0,Alopecia,6,16477128
2,22.0,Anxiety,6,16477128
0,22.0,Alopecia,6,16477135
1,22.0,Anxiety,6,16477135
2,22.0,Emotional distress,6,16477135
0,22.0,Emotional distress,6,16477140
1,22.0,Anxiety,6,16477140
2,22.0,Alopecia,6,16477140
0,22.0,Anxiety,6,16477146
1,22.0,Emotional distress,6,16477146
2,22.0,Alopecia,6,16477146
0,22.0,Alopecia,6,16477158
1,22.0,Anxiety,6,16477158
2,22.0,Emotional distress,6,16477158
0,22.0,Emotional distress,6,16477164
1,22.0,Anxiety,6,16477164
2,22.0,Alopecia,6,16477164
0,22.0,Emotional distress,6,16477166
1,22.0,Anxiety,6,16477166
2,22.0,Alopecia,6,16477166
0,22.0,Anxiety,6,16477169
1,22.0,Emotional distress,6,16477169
2,22.0,Alopecia,6,16477169
0,22.0,Alopecia,6,16477182
1,22.0,Emotional distress,6,16477182
2,22.0,Anxiety,6,16477182
0,22.0,Alopecia,6,16477185
1,22.0,Anxiety,6,16477185
2,22.0,Emotional distress,6,16477185
0,22.0,Alopecia,6,16477186
1,22.0,Emotional distress,6,16477186
2,22.0,Anxiety,6,16477186
0,22.0,Alopecia,6,16477189
1,22.0,Anxiety,6,16477189
2,22.0,Emotional distress,6,16477189
0,22.0,Alopecia,6,16477190
1,22.0,Anxiety,6,16477190
2,22.0,Emotional distress,6,16477190
0,22.0,Emotional distress,6,16477195
1,22.0,Anxiety,6,16477195
2,22.0,Alopecia,6,16477195
0,22.0,Emotional distress,6,16477196
1,22.0,Anxiety,6,16477196
2,22.0,Alopecia,6,16477196
0,22.0,Alopecia,6,16477200
1,22.0,Emotional distress,6,16477200
2,22.0,Anxiety,6,16477200
0,22.0,Pneumatosis intestinalis,2,16477239
1,22.0,Aortic thrombosis,1,16477239
0,22.0,Nephritis allergic,3,16477261
0,22.0,Pulmonary embolism,1,16477290
1,22.0,Embolism venous,1,16477290
0,22.1,Malignant neoplasm progression,3,16477303
0,22.0,Dyspnoea,1,16477321
1,22.0,Throat tightness,1,16477321
0,22.0,Drug interaction,6,16477389
1,22.0,Cardio-respiratory arrest,1,16477389
2,22.0,Metabolic acidosis,1,16477389
3,22.0,Acute kidney injury,1,16477389
4,22.0,Hyperkalaemia,1,16477389
0,22.0,Fatigue,2,16477408
1,22.0,Metastases to bone,6,16477408
2,22.0,Nasopharyngitis,6,16477408
3,22.0,Osteopenia,6,16477408
4,22.0,Metastases to lung,6,16477408
5,22.0,Neutropenia,6,16477408
0,22.0,Blood glucose increased,6,16477425
1,22.0,Pruritus,6,16477425
2,22.0,Rash,6,16477425
0,22.1,Pneumonia,2,16477440
1,22.1,Febrile neutropenia,2,16477440
0,22.0,Death,5,16477442
0,22.0,Death,5,16477449
0,22.0,Gastrointestinal disorder,6,16477459
1,22.0,Bone marrow failure,6,16477459
2,22.0,Cough,2,16477459
3,22.0,Productive cough,2,16477459
4,22.0,Hepatic function abnormal,6,16477459
0,22.0,Death,5,16477460
0,22.0,Chest discomfort,6,16477499
1,22.0,Osteoporosis,6,16477499
0,22.0,Infection,3,16477516
1,22.0,Arthralgia,6,16477516
2,22.0,Sepsis,6,16477516
0,22.0,Venoocclusive liver disease,3,16477518
0,22.0,Spinal pain,2,16477519
1,22.0,Back pain,1,16477519
2,22.0,Hypotension,1,16477519
0,22.1,Diarrhoea infectious,1,16477571
1,22.1,Pyrexia,1,16477571
0,22.0,Septic shock,1,16477576
1,22.0,Febrile bone marrow aplasia,1,16477576
0,22.0,Death,5,16477606
0,22.0,Death,5,16477607
0,22.0,Febrile bone marrow aplasia,1,16477637
0,22.0,Leukopenia,2,16477660
0,22.0,Death,5,16477662
0,22.1,Tooth abscess,6,16477663
1,22.1,White blood cell count decreased,6,16477663
2,22.1,Malaise,6,16477663
0,22.0,Diarrhoea,1,16477677
1,22.0,Rectal haemorrhage,1,16477677
0,22.0,Terminal state,3,16477680
0,22.0,Sarcoma uterus,6,16477683
1,22.0,Tumour invasion,6,16477683
0,22.0,Ventricular fibrillation,1,16477813
1,22.0,Cardiac arrest,1,16477813
0,22.0,Type I hypersensitivity,1,16477824
0,22.0,Vomiting,2,16477826
1,22.0,Cold sweat,2,16477826
2,22.0,Blood pressure decreased,3,16477826
3,22.0,Rash erythematous,2,16477826
0,22.0,Metastases to lymph nodes,6,16477839
1,22.0,Sarcoma uterus,6,16477839
2,22.0,Tumour invasion,6,16477839
0,22.0,Hepatotoxicity,5,16477869
0,22.0,Bile duct stenosis,6,16477871
0,22.1,Paraplegia,3,16477897
1,22.1,Accident,3,16477897
0,22.0,Haemolytic anaemia,6,16477913
1,22.0,Thrombocytopenia,1,16477913
0,22.0,Thrombocytopenia,1,16477917
0,22.0,Drug resistance,6,16477921
1,22.0,Pneumothorax,6,16477921
2,22.0,Metastases to lung,6,16477921
3,22.0,Intestinal stenosis,6,16477921
4,22.0,Intestinal ulcer,6,16477921
0,22.0,Haemorrhoids,3,16477948
1,22.0,Impaired healing,3,16477948
2,22.0,Back pain,2,16477948
3,22.0,Lip haemorrhage,2,16477948
4,22.0,Feeding disorder,3,16477948
5,22.0,Tremor,3,16477948
6,22.0,Rash,2,16477948
7,22.0,Constipation,3,16477948
8,22.0,Stomatitis,3,16477948
9,22.0,Abscess,6,16477948
10,22.0,Dry mouth,3,16477948
0,22.0,Death,5,16477955
1,22.0,Pneumonia,3,16477955
2,22.0,Hypokalaemia,3,16477955
3,22.0,Abdominal mass,6,16477955
4,22.0,Dysphagia,6,16477955
5,22.0,Red blood cell count decreased,6,16477955
6,22.0,Hypomagnesaemia,6,16477955
7,22.0,Carbohydrate antigen 125 increased,6,16477955
8,22.0,Decreased appetite,3,16477955
9,22.0,Anaemia,6,16477955
10,22.0,Blood magnesium decreased,6,16477955
11,22.0,Blood pressure decreased,3,16477955
12,22.0,Loss of consciousness,3,16477955
13,22.0,Pain,6,16477955
14,22.0,Constipation,3,16477955
15,22.0,Tachycardia,3,16477955
0,22.0,Blood urine present,1,16477973
1,22.0,Pain,1,16477973
0,22.0,Urinary bladder haemorrhage,3,16477988
1,22.0,Bladder mass,3,16477988
2,22.0,Prescribed underdose,6,16477988
0,22.0,Rhabdomyosarcoma,5,16478001
1,22.0,Somnolence,6,16478001
0,22.0,Intestinal obstruction,1,16478014
0,22.0,Renal failure,6,16478016
0,22.0,Somnolence,1,16478028
1,22.0,Hormone-refractory prostate cancer,5,16478028
0,22.0,Hypopituitarism,2,16478038
1,22.0,Ovarian vein thrombosis,1,16478038
0,22.0,Hypotension,1,16478102
0,22.0,Psoriasis,2,16478136
0,22.0,Posterior reversible encephalopathy syndrome,1,16478138
1,22.0,Rash,6,16478138
0,22.0,Nausea,6,16478156
1,22.0,Arthralgia,6,16478156
2,22.0,Thrombocytopenia,2,16478156
0,22.0,Arthralgia,2,16478170
0,22.1,Hypotension,6,16478176
1,22.1,Febrile neutropenia,6,16478176
0,22.1,Rib fracture,2,16478178
1,22.1,Fall,2,16478178
2,22.1,Fracture,2,16478178
0,22.0,Death,5,16478222
1,22.0,Malaise,6,16478222
2,22.0,Neoplasm progression,6,16478222
0,22.0,Malignant neoplasm progression,5,16478262
1,22.0,Pyrexia,2,16478262
2,22.0,Cough,6,16478262
3,22.0,Pneumonia,6,16478262
4,22.0,Cerebral infarction,6,16478262
5,22.0,Pneumonitis,3,16478262
0,22.0,Thrombocytopenia,1,16478300
1,22.0,Neoplasm progression,6,16478300
2,22.0,Disseminated intravascular coagulation,1,16478300
0,22.0,Ill-defined disorder,6,16478314
1,22.0,Injection site urticaria,6,16478314
2,22.0,Swelling,6,16478314
3,22.0,Blood bilirubin abnormal,1,16478314
4,22.0,Injection site urticaria,4,16478314
0,22.0,Jaw fistula,6,16478352
1,22.0,Osteonecrosis of jaw,6,16478352
2,22.0,Mucosal inflammation,6,16478352
0,22.0,Dyspnoea,1,16478361
1,22.0,Tachycardia,1,16478361
2,22.0,Flushing,1,16478361
3,22.0,Feeling hot,1,16478361
4,22.0,Chest pain,1,16478361
0,22.1,Osteopenia,6,16478367
1,22.1,Spinal compression fracture,6,16478367
2,22.1,Fatigue,6,16478367
3,22.1,Musculoskeletal pain,6,16478367
4,22.1,Mouth ulceration,6,16478367
0,22.0,Pneumonitis,6,16478416
0,22.0,Movement disorder,3,16478469
1,22.0,Nausea,3,16478469
2,22.0,Malaise,3,16478469
3,22.0,Taste disorder,3,16478469
4,22.0,Confusional state,3,16478469
5,22.0,Fatigue,6,16478469
6,22.0,Vein disorder,6,16478469
7,22.0,Dizziness,3,16478469
8,22.0,Weight decreased,6,16478469
9,22.0,Vomiting,3,16478469
10,22.0,Osteoarthritis,3,16478469
11,22.0,Neoplasm progression,6,16478469
12,22.0,Abdominal pain,6,16478469
0,22.0,Diarrhoea,2,16478475
1,22.0,Presyncope,1,16478475
2,22.0,Nasopharyngitis,1,16478475
3,22.0,Pulmonary embolism,1,16478475
4,22.0,Nail toxicity,3,16478475
5,22.0,Mucosal inflammation,1,16478475
6,22.0,Arthralgia,1,16478475
7,22.0,Constipation,1,16478475
8,22.0,Alopecia,1,16478475
9,22.0,Gamma-glutamyltransferase increased,2,16478475
10,22.0,Peripheral sensory neuropathy,2,16478475
11,22.0,Fatigue,2,16478475
0,22.1,Mood altered,6,16478482
1,22.1,Fall,6,16478482
2,22.1,Bone lesion,3,16478482
3,22.1,Alopecia,6,16478482
4,22.1,Gait disturbance,6,16478482
5,22.1,White blood cell count decreased,6,16478482
6,22.1,Malaise,6,16478482
7,22.1,Nasopharyngitis,2,16478482
8,22.1,Weight decreased,6,16478482
9,22.1,Fatigue,6,16478482
10,22.1,Joint injury,6,16478482
11,22.1,Pain,6,16478482
0,22.0,Dizziness,6,16478505
0,22.0,Vaginal haemorrhage,6,16478508
0,22.0,Hair colour changes,6,16478510
1,22.0,Death,5,16478510
2,22.0,Nausea,6,16478510
3,22.0,Rash macular,6,16478510
4,22.0,Stomatitis,6,16478510
0,22.0,Migraine,6,16478513
0,22.1,Blood test abnormal,1,16478517
1,22.1,Hypoacusis,6,16478517
2,22.1,Drug effective for unapproved indication,6,16478517
3,22.1,Mental disorder,6,16478517
4,22.1,Off label use,6,16478517
5,22.1,Aphonia,6,16478517
0,22.0,Malaise,6,16478557
1,22.0,Fatigue,3,16478557
